Serotonin modulates immune function in T cells from HIV-seropositive subjects

被引:34
作者
EugenOlsen, J [1 ]
Afzelius, P [1 ]
Andresen, L [1 ]
Iversen, J [1 ]
Kronborg, G [1 ]
Aabech, P [1 ]
Nielsen, JO [1 ]
Hofmann, B [1 ]
机构
[1] COPENHAGEN UNIV HOSP,DEPT CLIN IMMUNOL 443,DK-2650 HVIDOVRE,DENMARK
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1997年 / 84卷 / 02期
关键词
D O I
10.1006/clin.1997.4384
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have shown earlier increased intracellular levels of cAMP in peripheral lymphocytes from HIV-seropositive subjects and that a chemically induced decrease in this level increases cell proliferation and cytotoxicity. Others have shown that serotonin indirectly decreases intracellular cAMP levels in normal peripheral lymphocytes. In this study, we show that addition of serotonin decreases intracellular levels of cAMP in lymphocytes from EW-seropositive subjects and significantly increases the proliferative capacity in vitro. However, the effect of serotonin varies with the initial proliferative response; e.g., those with the highest initial responses have the highest increases. An increase in IL-2 production may be a part of this mechanism since addition of serotonin to in vitro cultures of PHA-stimulated cells increases the expression of mRNA for IL-2 and IFN-gamma. The effect on lymphocyte proliferation was most likely mediated through the serotonin 5HT1a receptor because similar results could be obtained by using DPAT, a specific activator of this receptor. Changes in the expression of 5HT1a receptors as judged by the expression of mRNA could not explain why serotonin in vitro had a stronger enhancing effect on cell proliferation in some HIV-seropositive individuals than in others. (C) 1997 Academic Press.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 29 条
  • [1] AUNE TM, 1993, J IMMUNOL, V151, P1175
  • [2] AUNE TM, 1994, J IMMUNOL, V153, P489
  • [3] CONTROL OF HUMAN LYMPHOCYTE-T INTERLEUKIN-2 PRODUCTION BY A CAMP-DEPENDENT PATHWAY
    AVERILL, LE
    STEIN, RL
    KAMMER, GM
    [J]. CELLULAR IMMUNOLOGY, 1988, 115 (01) : 88 - 99
  • [4] cAMP-dependent protein kinase: Role in normal and malignant growth
    ChoChung, YS
    Pepe, S
    Clair, T
    Budillon, A
    Nesterova, M
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1995, 21 (1-3) : 33 - 61
  • [5] THE REGULATORY SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE AS A TARGET FOR CHEMOTHERAPY OF CANCER AND OTHER CELLULAR DYSFUNCTIONAL-RELATED DISEASES
    CHOCHUNG, YS
    CLAIR, T
    [J]. PHARMACOLOGY & THERAPEUTICS, 1993, 60 (02) : 265 - 288
  • [6] DIDIER M, 1987, J IMMUNOL, V139, P1179
  • [7] FAN J, 1993, J IMMUNOL, V151, P5031
  • [8] THE GENOMIC CLONE G-21 WHICH RESEMBLES A BETA-ADRENERGIC-RECEPTOR SEQUENCE ENCODES THE 5-HT1A RECEPTOR
    FARGIN, A
    RAYMOND, JR
    LOHSE, MJ
    KOBILKA, BK
    CARON, MG
    LEFKOWITZ, RJ
    [J]. NATURE, 1988, 335 (6188) : 358 - 360
  • [9] TREATMENT OF THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
    GUPTA, S
    GOTTLIEB, MS
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1986, 6 (03) : 183 - 193
  • [10] IMMUNOSUPPRESSIVE RETROVIRAL PEPTIDES - CAMP AND CYTOKINE PATTERNS
    HARAGUCHI, S
    GOOD, RA
    DAY, NK
    [J]. IMMUNOLOGY TODAY, 1995, 16 (12): : 595 - 603